Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients

By J. Kirchner, Ioana Plesca, Rebecca Rothe, Antonia Resag, S. Löck, I. Benešová, Luise Rupp, Annett Linge, R. Wehner, Mechthild Krause and 1 more. 2024

Subfields: Immunology, Oncology, Otorhinolaryngology